Directive 2006/86/EC
E617258
Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Directive 2006/86/EC canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T6769629 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Directive 2006/86/EC Context triple: [EU Tissues and Cells Directives, includes, Directive 2006/86/EC]
-
A.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
B.
Directive 2001/82/EC
Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
-
C.
Council Directive 2001/86/EC
Council Directive 2001/86/EC is a European Union legal act that supplements the Statute for a European Company (Societas Europaea) by establishing rules on employee involvement in such companies.
-
D.
Directive 2009/147/EC
Directive 2009/147/EC is a key European Union law on the conservation of wild birds, forming one of the main legal pillars of the Natura 2000 protected areas network.
-
E.
Directive 2003/41/EC
Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Directive 2006/86/EC Target entity description: Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
-
A.
Directive 2001/83/EC
Directive 2001/83/EC is a key European Union law that sets the framework for the authorization, manufacture, distribution, and pharmacovigilance of medicinal products for human use across EU member states.
-
B.
Directive 2001/82/EC
Directive 2001/82/EC is a key European Union law that sets out the rules for the authorization, supervision, and pharmacovigilance of veterinary medicinal products across EU member states.
-
C.
Council Directive 2001/86/EC
Council Directive 2001/86/EC is a European Union legal act that supplements the Statute for a European Company (Societas Europaea) by establishing rules on employee involvement in such companies.
-
D.
Directive 2009/147/EC
Directive 2009/147/EC is a key European Union law on the conservation of wild birds, forming one of the main legal pillars of the Natura 2000 protected areas network.
-
E.
Directive 2003/41/EC
Directive 2003/41/EC was the original EU framework setting prudential and supervision rules for institutions for occupational retirement provision (IORPs) before being updated and replaced by the IORP II Directive.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
EU secondary legislation
ⓘ
European Union directive ⓘ |
| adoptedBy | European Commission NERFINISHED ⓘ |
| aimsTo |
ensure a high level of human health protection
ⓘ
ensure full traceability of tissues and cells from donor to recipient ⓘ ensure full traceability of tissues and cells from recipient to donor ⓘ harmonise technical requirements in the EU for tissues and cells ⓘ |
| appliesTo | Member States of the European Union NERFINISHED ⓘ |
| basedOn | Article 152 of the EC Treaty (public health) NERFINISHED ⓘ |
| complements | Directive 2004/23/EC NERFINISHED ⓘ |
| concerns |
protection of donors of human tissues and cells
ⓘ
safety of recipients of human tissues and cells ⓘ |
| contains |
requirements for documentation and data protection
ⓘ
requirements for inspection and control measures ⓘ requirements for notification of serious adverse events ⓘ requirements for notification of serious adverse reactions ⓘ requirements for quality management systems in tissue establishments ⓘ |
| dateAdopted | 24 October 2006 ⓘ |
| enteredIntoForce | 20 days after its publication in the Official Journal of the European Union ⓘ |
| fullTitle | Commission Directive 2006/86/EC of 24 October 2006 NERFINISHED ⓘ |
| geographicalScope | European Union NERFINISHED ⓘ |
| implements | Directive 2004/23/EC NERFINISHED ⓘ |
| languageOfTitle | English ⓘ |
| legalBasis | Directive 2004/23/EC NERFINISHED ⓘ |
| partOf | European Union law ⓘ |
| policyArea | health and consumer protection ⓘ |
| publishedIn | Official Journal of the European Union NERFINISHED ⓘ |
| regulates |
coding and labelling of human tissues and cells
ⓘ
import and export of human tissues and cells ⓘ record-keeping for human tissues and cells ⓘ storage and distribution of human tissues and cells ⓘ tissue establishments ⓘ |
| requires |
Member States to designate competent authorities for tissues and cells
NERFINISHED
ⓘ
Member States to establish systems for traceability of tissues and cells NERFINISHED ⓘ maintenance of records for at least 30 years ⓘ reporting of serious adverse reactions and events to competent authorities ⓘ |
| sector |
medical treatments
ⓘ
public health ⓘ |
| sets |
standards for distribution conditions of tissues and cells
ⓘ
standards for documentation accompanying tissues and cells ⓘ standards for donor identification and coding ⓘ standards for labelling of tissues and cells ⓘ standards for storage conditions of tissues and cells ⓘ |
| subject |
donation, procurement and testing of human tissues and cells
ⓘ
human tissues and cells ⓘ notification of serious adverse reactions and events ⓘ quality and safety of human tissues and cells ⓘ traceability of human tissues and cells ⓘ |
| typeOfMeasure | technical implementing directive ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Directive 2006/86/EC Description of subject: Directive 2006/86/EC is a European Union legal act that sets detailed technical requirements for the traceability, notification of serious adverse reactions and events, and quality and safety standards for human tissues and cells used in medical treatments.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.